Cineworld Share Price (CINE)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Cineworld	LSE:CINE	London	Ordinary Share	GB00B15FWH70	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+0.00p	+0.00%	711.50p	712.50p	714.00p	-	-	-	0	06:41:48

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Travel & Leisure	797.8	98.2	30.8	23.1	1,931.72

Related Shares
Compass Group (CPG), Ryanair Hldg. (RYA), Challenger (CHAL), Snoozebox (ZZZ)

Cineworld (CINE) Latest News

Cineworld News

Date	Time	Source	Headline
14/8/2017	15:10	ALNC	Cineworld Issues Shares As Deferred Consideration For Empire Buy (ALLISS)
14/8/2017	14:58	ALNCF	Alliance News Flash Headline
14/8/2017	14:55	UKREG	Cineworld Group plc Allotment and Issue of New Ordinary Shares
10/8/2017	14:03	ALNC	IN THE KNOW: Buy "Lone Shining Star" Cineworld After Strong Half - N+1
10/8/2017	13:08	ITALNC	LONDON MARKET MIDDAY: FTSE 100 in calo, prevale avversione al rischio
10/8/2017	08:34	ALNC	TOP NEWS: Blockbusters Boost Cineworld Sales As Interim Profit Jumps
10/8/2017	07:01	UKREG	Cineworld Group plc Half-year Report
01/8/2017	11:04	UKREG	Cineworld Group plc Total Voting Rights
28/7/2017	12:45	UKREG	Cineworld Group plc Holding(s) in Company
17/7/2017	17:15	UKREG	Cineworld Group plc Allotment and Issue of New Ordinary Shares

More Cineworld News

Cineworld Takeover Rumours

Cineworld (CINE) Share Charts

1 Year Cineworld Chart

1 Month Cineworld Chart

Intraday Cineworld Chart

Cineworld (CINE) Discussions and Chat

Cineworld Forums and Chat

Date	Time	Title	Posts
10/8/2017	09:14	CINEWORLD	1,606
19/11/2014	14:16	Cineworld (CINE) - IMS	-
27/10/2009	18:37	CINE: 165p resistance..	2
13/2/2009	00:04	Cineworld (LSE:CINE) into administration?	1
04/7/2007	08:51	welcome to the cinema	3

Add a New Thread

Cineworld (CINE) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2017-08-17 15:59:04	713.35	563	4,016.17	NT
2017-08-17 15:57:00	713.35	3,043	21,707.29	NT
2017-08-17 15:55:52	713.35	2,764	19,717.04	NT
2017-08-17 15:44:26	713.84	154	1,099.32	NT
2017-08-17 15:35:19	711.50	58,376	415,345.24	UT

View all Cineworld trades in real-time

Cineworld (CINE) Top Chat Posts

Date	Subject
17/8/2017 09:20	Cineworld Daily Update: Cineworld is listed in the Travel & Leisure sector of the London Stock Exchange with ticker CINE. The last closing price for Cineworld was 711.50p. Cineworld has a 4 week average price of 676p and a 12 week average price of 670p. The 1 year high share price is 744.50p while the 1 year low share price is currently 528p. There are currently 271,500,255 shares in issue and the average daily traded volume is 972,572 shares. The market capitalisation of Cineworld is £1,931,724,314.33. Read Full Thread Reply
10/5/2017 17:41	sharw: "I just dont see its run of growth continuing ..." Are you referring to the company or the share price? Having listened to some of Mooky Greidinger's presentations I have no doubt about the company's ability to grow. However the share price growth has outpaced that recently as the market has belatedly recognised some of the qualities as described by smokybenchod above. My hunch is that the current rating will broadly be retained meaning that the share price will now grow in line with the company's growth. As you have a substantial profit one tactic could be to 'top slice' (part sell) if you have something else to put the proceeds into. Read Full Thread Follow Reply
23/4/2016 02:57	lauders: Mixed messages here! The last RNS states in increase in institutional holdings (over 5%), the Sheffield presentation looked good to me (see below & the progress with refurbishments & the Starbucks alliance that seems to be gaining traction), yet the share price is showing weakness. Hope that a few broker notes that reflect the progress are issued next week or soon! Http://www.cineworldplc.com/~/media/Files/C/Cineworld-PLC/reports-and-presentations/2016-analyst-day.pdf Read Full Thread Follow Reply
19/3/2016 01:43	lauders: Seems CINE was upgraded by Canaccord Genuity to a target of 520p from 500p yesterday. Wow! Big target that has already been surpassed. They increase based on: ".... increasing the chain's fiscal 2016 EPS forecast 5.0% to 31.3p and 2017's by 6.8% to 33.9p and is introducing a 2018 forecast of 37.1p. Says the growth is mostly driven by a lower tax charge and the rollout of new multiplexes rather than any material improvement in trading." They retain a "hold rating", which usually means sell in broker jargon! Helped with the share price today but will hopefully go much higher and smash their already beaten "target". Brokers! Not worth the time from experience. Read Full Thread Follow Reply
10/3/2016 12:52	soundbuy: Cazenove. Cineworld had what we regard as a very strong year in 2015. EBITDA was up 18.5% on a proforma basis to £155m, 1% above our estimate. A record 18 new sites were opened across the estate. 2016 has started well, especially in CEE and Israel, but the UK has also been solid and in line with expectations. Our EPS estimates increase by 3% in both FY16 and FY17. We remain Overweight with an increased price target of 610p, March 2017 (was 600p to Dec-16).  Solid headline performance. Revenue was up 13.9% (12.4% proforma) to £706m, in line with our estimate of £707m. EBITDA was £155.3m, 1% above our estimate of £154.2m. Adjusted PBT was £102.8m, up 37% and above our estimate of £94.1m and Bloomberg consensus of £96.2m due mainly to a lower depreciation charge. Adjusted EPS was 31.7p, which was above our estimate of 27.9p and Bloomberg consensus of 28.3p due to lower depreciation and a lower effective tax rate.  Margin expansion. As well as increasing overall admissions by 6.5%, Cineworld achieved growth in average ticket prices and retail spend per person. This, coupled with operating cost efficiencies, allowed the EBITDA margin to expand from 20.4% to 22.0%.  Outlook is positive. We believe the outlook for further growth in 2016 is very positive. We expect a further 13 new sites to be opened (6 in the UK and 7 in CEE/Israel). We also believe that Cineworld's business model will see it outperform the UK box office in 2016.  Changes to earnings estimates. There are no material changes to our adjusted EBITDA estimates, which remain £170m in FY16 and £185m in FY17. The assumption of a lower depreciation charge means our operating profit estimates increase by 3% from £114.1m to £117.4m in FY16 and by 2% from £125.3m to £128.4m in FY17. Our adjusted EPS estimates increase by 3% from 32.3p to 33.2p in FY16 and by 3% from 35.4p to 36.4p in FY17. Canaccord. Cineworld's FY15 results were slightly ahead of consensus driven by the UK Other line which includes film advertising. But we believe it could have been so much better. Cineworld lost UK box office market share in FY15 and we estimate that it could be missing out on as much as £2.2m of additional EBITDA per blockbuster in the UK. Assuming a blockbuster/quarter that puts Cineworld’s missed UK opportunity at £8.8m. For Bond, Hunger Games and Star Wars, the scale of the missed opportunity could have been as much as £6.6m. The FY16 film slate is weaker and we do not expect consensus to change materially. We retain our HOLD recommendation as the share price is below our target price. Detail Cineworld reported FY15 EBITDA of £155.3m (+22.7%) and Adj PBT of £102.8m (+37.15) with both reporting divisions performing equally well. To put performance into context, Cineworld lost UK market share with box office revenue +8.0% versus market +17.4%. Q1 has been saved by Deadpool, but the film slate is weaker this year with the mix to more family films and less blockbusters, no material change to consensus is expected at this stage. The openings programme is on track: 18 new cinemas opened in FY15 and Cineworld will continue to open 13-14 new multiplexes per annum from now on. The dividend was +30% to 17.5p and net debt/EBITDA reduced by £37m to £282m. Cineworld can fund all requirements from cashflow. Cineworld has appointed Mr Dean Moore as interim CFO for 12 months pending the promotion of Nissan Cohen to the job, who becomes deputy CFO. Valuation Yesterday's closing share price of 480p values the stock on a P/E of 16.1x for FY16E and 15.1x for FY17E, and EV/EBITDA of 8.9x falling to 8.2x, and FCF yield of 9.2% rising to 9.9%. Our 500p share price target is based on a PE of 16.8x, an EV/EBITDA of 9.2x and 8.8% FCF for FY16E. The default Quest® valuation is 302p. The stock has performed relatively well compared to IMAX and Cineplex. Our CG preferred stock remains IMAX (IMAX : NYSE : US$32 \| BUY, TP: US$37). Read Full Thread Follow Reply
05/3/2016 02:40	lauders: Thanks SoundBuy! Not sure why brokers can't wait until AFTER results to issue such notes? They would surely have more "facts" to use than predicting beforehand? Looks like the price was rising "for no apparent reason" and UBS took advantage of that to knock them back a bit. The cynic in me would say this was done so one of their clients could load-up before results, but what do I know? They may well be turning around and issuing a buy note next week and then the share price will hardly move. Quite amazing how the market works sometimes. leadersoffice - Very astute investment advice LOL! Perhaps you should provide a bit more substance than that, looks rather weak and rampy IMO. To their credit UBS do hit on an interesting point and that is the demographics of CEE countries may be changing and this might have an effect. Not sure about the children's films point. The CEE have their own productions and not sure how many are children focused ones. The point about lower admission fees in the UK is also interesting, but surely that would attract MORE people and thereby keep their premises busier than their competitors? Arguments for and against as usual! The other side of the coin and more positive opinions: Http://www.emqtv.com/numis-securities-ltd-reaffirms-add-rating-for-cineworld-group-plc-cine/218026/ Numis was the most recent with "add" before UBS came along to spoil the "party"! All will be revealed on 10th March when results are released! Read Full Thread Follow Reply
31/10/2015 12:39	lauders: Well this is confusing! Below are both notes from the same "broker" a week apart. Nothing like confusing your clients! Perhaps one client liked the original one so much and agreed so much they convinced Canaccord to issue another contrary one so they could load-up! Surely the FSA should look into obvious cases like this? Seems crazy! Canaccord has latched onto Bond-mania with the release of Sceptre, the latest film in the long-running franchise, on Monday to repeat its ‘buy’ rating on cinema chain Cineworld (LON;CINE). But it is the less racy expansion opportunity for the chain in eastern Europe that has got the broker’s juices running. An analysts’ trip to Romania confirmed the commanding position in a growing market held by Cineworld in a country where there is little competition said the broker. Subsidiary Cinema City operates 21 of 34 multiplexes in Romania with plans to take it to 40 multiplexes in the next five years. Cineworld also makes more money per pound of investment in Romania that anywhere else. The 40 multiplex target is realistic, believes Canaccord, as Romania has a population of 20mln and there are 23 cities with a population of over 100,000. James Bond and Star Wars excitement meanwhile has led to problems coping with the demand. Canaccord said Cineworld had confirmed its website had crashed along with its rivals due to the surge of interest, with as many ticket requests for Star Wars in a day as normally come in over three months. Buy with a 620p target price says the broker. Cannacorde note....We are reducing our Cineworld recommendation to SELL from Buy with a new, lowered share price target of 535p (from 620p), implying c10% downside. It’s time to take profits. Cineworld’s share price is up 75% over the last 12 months driven in large part by this year’s fantastic film slate that climaxes this quarter with three blockbusters: Bond Spectre, Hunger Games: Mockingjay Part 2 and Star Wars: the Force Awakens yet Cineworld traditionally under-indexes versus Odeon and Vue on blockbusters and our research suggests this quarter will be no exception. This quarter is as good as it gets for the cinema industry. Next year's film slate is less strong and it could be a 'crowded trade' when the market wakes up to a duller outlook not helped by the distractions of the Olympics and the UEFA European Football Championships next summer.Our analysis round the three autumn blockbusters shows that Odeon is more aggressive on the allocation of screens and Vue is more aggressive on price. Cineworld does not believe in revenue yield optimization. Until it does, we believe it will continue to underperform during industry peaks. We are coming to the view that Cineworld is better at building cinemas in unsophisticated East Europe where competition is weak than optimizing performance from its sophisticated UK portfolio where competition is intense. We estimate Cineworld could be missing out on as much as £2.2m of additional EBITDA per blockbuster in the UK. Assuming a blockbuster/quarter that puts Cineworld’s missed UK opportunity at £8.8m. For 4Q15, with three potential blockbusters, the scale of the missed opportunity may be as much as £6.6m. To put this in context, the UK accounts for c65% of Cineworld EBIT and we are forecasting an H2 EBIT contribution of £44.7m for the UK and £65.4m for group EBIT. It’s a very material lost opportunity for Cineworld. Potential year-end upgrades should not be mistaken for an excellent performance: a rising tide lifts all ships. Our new 535p target price valuation is equivalent to 18.8x PER, 10.0x EV/EBITDA, an 8.0% FCF yield and 3.0% dividend yield for FY15E. The current share price of 594p values the stock on a P/E of 20.9x for FY15E, 18.9x FY16E, an EV/EBITDA of 10.9x falling to 10.0x, a FCF yield of 7.2% rising to 7.9% and dividend yield of 2.7% rising to 2.9% over the same period. It now looks an expensive stock following its re-rating over the last 12 months. Anyone else confused? Read Full Thread Follow Reply
30/10/2015 11:58	market sniper1: We are reducing our Cineworld recommendation to SELL from Buy with a new, lowered share price target of 535p (from 620p), implying c10% downside. It’s time to take profits. Cineworld’s share price is up 75% over the last 12 months driven in large part by this year’s fantastic film slate that climaxes this quarter with three blockbusters: Bond Spectre, Hunger Games: Mockingjay Part 2 and Star Wars: the Force Awakens yet Cineworld traditionally under-indexes versus Odeon and Vue on blockbusters and our research suggests this quarter will be no exception. This quarter is as good as it gets for the cinema industry. Next year's film slate is less strong and it could be a 'crowded trade' when the market wakes up to a duller outlook not helped by the distractions of the Olympics and the UEFA European Football Championships next summer.Our analysis round the three autumn blockbusters shows that Odeon is more aggressive on the allocation of screens and Vue is more aggressive on price. Cineworld does not believe in revenue yield optimization. Until it does, we believe it will continue to underperform during industry peaks. We are coming to the view that Cineworld is better at building cinemas in unsophisticated East Europe where competition is weak than optimizing performance from its sophisticated UK portfolio where competition is intense. We estimate Cineworld could be missing out on as much as £2.2m of additional EBITDA per blockbuster in the UK. Assuming a blockbuster/quarter that puts Cineworld’s missed UK opportunity at £8.8m. For 4Q15, with three potential blockbusters, the scale of the missed opportunity may be as much as £6.6m. To put this in context, the UK accounts for c65% of Cineworld EBIT and we are forecasting an H2 EBIT contribution of £44.7m for the UK and £65.4m for group EBIT. It’s a very material lost opportunity for Cineworld. Potential year-end upgrades should not be mistaken for an excellent performance: a rising tide lifts all ships. Our new 535p target price valuation is equivalent to 18.8x PER, 10.0x EV/EBITDA, an 8.0% FCF yield and 3.0% dividend yield for FY15E. The current share price of 594p values the stock on a P/E of 20.9x for FY15E, 18.9x FY16E, an EV/EBITDA of 10.9x falling to 10.0x, a FCF yield of 7.2% rising to 7.9% and dividend yield of 2.7% rising to 2.9% over the same period. It now looks an expensive stock following its re-rating over the last 12 months. Read Full Thread Follow Reply
13/8/2015 13:51	mike740: Cineworld Group plc given a Potential Upside of 33.8% Suggested by Citigroup Posted by: Amilia Stone 11th August 2015, updated 13th August 2015 Cineworld Group plc using EPIC code LON:CINE has had its stock rating noted as ‘Initiates/Starts’ with the recommendation being set at ‘BUY’ today by analysts at Citigroup. Cineworld Group plc are listed in the Consumer Services sector within UK Main Market. Citigroup have set their target price at 720 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 33.8% from the opening price of 538 GBX. Cineworld Group plc LON:CINE has a 50 day moving average of 495.38 GBX and a 200 day moving average of 454.10 GBX. The 1 year high share price is 545.42 GBX while the year low stock price is currently 298.4 GBX. Read Full Thread Follow Reply
25/1/2015 17:12	cockneyrebel: CINEMA: New 4DX screen coming to Cineworld, Milton Keynes to stimulate all the senses http://www.mkweb.co.uk/CINEMA-New-4DX-screen-coming-Cineworld-Milton/story-25831050-detail/story.html A sneak preview of Swindon's new Cineworld http://www.swindonadvertiser.co.uk/news/11731671.A_sneak_preview_of_Swindon_s_new_Cineworld/ Peel Hunt has great expectations (a great David Lean movie by the way, not to mention the book) for cinema group Cineworld (LON:CINE) in 2015, despite a tough time for the UK box office last year. It has repeated a 'buy' rating on the stock and given a fairly punchy target price price - moving to 440p from 393p. Data released yesterday showed UK and Ireland box office receipts fell by 2.9% to £1.13bn last year. Analyst Nick Batram said: "However, this comes as no surprise in a year of relatively few real blockbusters and the distraction of a World Cup. "Whilst the rerating at Cineworld, on the prospects of a recovery in box office in 2015, has come through quicker than expected, the potential upside to forecasts is significant. "Although there may be some short-term share price consolidation we are happy to retain our 'Buy' recommendation given the potential outperformance over 2015 http://www.proactiveinvestors.co.uk/columns/broker-spotlight/17564/broker-spotlight-cineworld-marshalls-william-hill-dixons-carphone-regency-mines-and-ortac--17564.html Read Full Thread Follow Reply
30/1/2014 09:17	enami: So the rights issue shares are now in the sysytem EPIC code LSE:CINN. Should trade at the current CINE share price minus the 230p subscription price. For every 1000 old CINE share you should have now 320 Rights. If you sold say 200 of the rights now it will be enough for the subscription to take up your rights for the remaining 120. CINN = 132.25 vs 360.65 as I type so the rights slightly more valuable than I caculated earlier. TD Direct have not caught up yet so I cannot sell. Read Full Thread Follow Reply

Cineworld share price data is direct from the London Stock Exchange

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:42 V: D:20170818 07:02:46